It works by mimicking a hormone called glucagon-like peptide-1 (GLP-1) that targets areas of the brain that regulate appetite and food intake
In my practice as a bariatric surgeon, I've seen firsthand the advantages of GLP-1 agonists, but I've also noticed a pattern of misuse and misunderstanding regarding their role, particularly in the treatment of morbid obesity
Lehman1,4,5 1 Department of Pathology and Laboratory Medicine, University of Louisville, Louisville, KY, USA 2 Department of Neurological Surgery, University of Louisville, Louisville, KY, USA 3 Department of Internal Medicine, University of Louisville, Louisville, KY, USA 4 The Brown Cancer Center, University of Louisville, Louisville, KY, USA 5 Department of Biochemistry and Molecular Genetics, University of Louisville, Louisville, KY, USA 6 Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA Corresponding author: Norman L
Understanding this distinction is essential for patients considering treatment options for diabetes or weight management
Following incubation, luciferase activity was detected by adding an equal volume of luciferase assay reagent (GM-040505C, GMBrightOne-Step, Genomeditech) to each well